Literature DB >> 10882213

Idiopathic inflammatory muscle disease: clinical aspects.

L G Rider1, F W Miller.   

Abstract

Although much remains to be learned about the immune-mediated myositis syndromes, information generated from recent studies in a number of areas may assist physicians in patient management. Topics reviewed here include: data supporting the association of myositis with cancer and the appropriate evaluations for malignancy in a myositis patient; an approach to the assessment of patients with dermatomyositis sine myositis; the usefulness of the clinicopathological and serological classifications; a discussion of whether childhood and adult myositis are the same or different entities; a review of those prognostic factors to consider in the clinical management of myositis patients; current approaches and their limitations for assessing disease activity and damage. To improve our limited understanding of the myositis syndromes, national and international collaborations are needed to obtain the necessary numbers of subjects, given the rarity and heterogeneity of these disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882213     DOI: 10.1053/berh.1999.0076

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  7 in total

1.  Inflammatory muscle disease assessment.

Authors:  Tim Y-T Lu; Kristine P Ng; David A Isenberg
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 2.  Paraneoplastic rheumatic syndromes.

Authors:  Csilla András; Zoltán Csiki; Andrea Ponyi; Arpád Illés; Katalin Dankó
Journal:  Rheumatol Int       Date:  2005-08-10       Impact factor: 2.631

3.  On Determining the Effects of Therapy on Disease Damage in Non- randomized Studies with Multiple Treatments: A study of Juvenile Myositis.

Authors:  Peter A Lachenbruch; Frederick W Miller; Lisa G Rider
Journal:  Commun Stat Theory Methods       Date:  2009-01-01       Impact factor: 0.893

Review 4.  Paediatric idiopathic inflammatory muscle disease: recognition and management.

Authors:  Clarissa A Pilkington; Lucy R Wedderburn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians.

Authors:  Gulnara Mamyrova; Terrance P O'Hanlon; Jason B Monroe; Danielle Mercatante Carrick; James D Malley; Sharon Adams; Ann M Reed; Ejaz A Shamim; Laura James-Newton; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2006-12

Review 6.  Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies.

Authors:  J H Park; N J Olsen
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.686

7.  Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma.

Authors:  Seung-Jung Kee; Tae-Jong Kim; Sung-Ji Lee; Young-Nan Cho; Seong-Chang Park; Jong-Sun Kim; Jeong-Chul Kim; Hyung-Sik Kang; Shin-Seok Lee; Yong-Wook Park
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 3.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.